54
Participants
Start Date
November 30, 2005
Primary Completion Date
December 1, 2008
RTA 744
Aqueous solution added to 10%D/W and infused over 2 hours on three consecutive days. 5 mg vials contain 1 mg/ml.
RTA 744 injection
Aqueous solution in 1mg/ml. Doses are escalated. Drug is infused intravenously over 2 hours one day a week for four consecutive weeks.
Baylor University Medical Center: Neuro-Oncology Associates, Dallas
University of Texas Southwestern Medical Center, Dallas
The University of Texas M. D. Anderson Cancer Center, Houston
UCLA School of Medicine, Department of Neurology, Los Angeles
Lead Sponsor
Biogen
INDUSTRY